Rossari Biotech Limited IPO: Issue Price, Listing Gain and Share Price Now
Rossari Biotech Limited listed on 23-Jul-2020 at ₹742.35 against an issue price of ₹425 , a listing gain of +74.67%. It last traded at ₹509.15. This page is the record of that issue and what has happened to it since — reported figures only.
Rossari Biotech Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹425 |
| Listing price (listing-day close) | ₹742.35 |
| Listing gain | +74.67% |
| Price now | ₹509.15 |
| Change from issue price | +19.80% |
| Change from listing-day close | -31.41% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Rossari Biotech Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹425 |
| Issue size | ₹496.25 Cr |
| Fresh issue | ₹50 Cr |
| Offer for sale | ₹446.25 Cr |
| Issue opened | 13-Jul-2020 |
| Issue closed | 15-Jul-2020 |
| Listed on | 23-Jul-2020 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Axis Bank (left lead) |
How the Rossari Biotech Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 85.26x |
| NII | 239.83x |
| Retail | 7.23x |
| Total | 79.37x |
Rossari Biotech Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹2,835 Cr |
| Trailing P/E | 18.80x |
| Return on capital employed | 13.3% |
| Return on equity | 10.8% |
| 52-week high | ₹691 |
| 52-week low | ₹373 |
| Sector | Specialty Chemicals |
Fundamentals are as of the desk's last harvest and move with the market.
- Rossari Biotech Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.